2 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Withdrawn 2 |
Follow Major Depression: new trials by email Literature Review of Major Depression trials Research Report on Major Depression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vortioxetine for the Treatment of Major Depression and Co-morbidities After Traumatic Brain Injury (TBI) Vortioxetine, Placebo - TBI, Major Depression | Phase 3 | Withdrawn | Johns Hopkins University | 2016-10-01 | 2016-09-02 | |
| Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents Citalopram - Major Depression | Phase 3 | Withdrawn | Sunnybrook Health Sciences Centre | 60 | 2002-09-01 | 2006-09-19 |
Depressive Disorder, Major (2)
Depressive Disorder (2) · Mental Disorders (2) · Mood Disorders (2)
Citalopram (1) · Sugars (1) · Vortioxetine (1)
Johns Hopkins University (1) · Sunnybrook Health Sciences Centre (1)
Canada (1)
Anthony J Levitt, MD (1) · Vani Rao, MD (1)